Contracts › 75A50126C00005
75A50126C00005: The Purpose of This Award Is to Advance the Development of Isola's Nebulization Therapy, a Medical Countermeasure Designed to Prevent and Treat Pulmonary Foam the Inhalation of Chemical Agents Causes.
Awarded to Isola Therapeutics Inc by Office of Assistant Secretary for Preparedness and Response.
$7.5Mobligated
$7.5Mpotential value
31 October 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50126C00005 |
|---|---|
| Awardee | Isola Therapeutics Inc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN13 Health R&D Services; Health Care Services; Experimental Development |
| Place of performance | MN |
| Offers received | 1 |
| Period of performance | 01 May 2026 to 31 October 2028 |
| Potential end | 31 October 2028 |
| Estimated recompete solicitation | ~Q2 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record